SHIVA02 Trial: Using Patients as Their Own Controls to Assess Efficacy of Therapies Based on Molecular Profiling in Patients with Refractory Cancer.

du Rusquec P, Dupain C, Geiss R, Sablin MP, Castel-Ajgal Z, Cassier P, Italiano A, Borcoman E, Klijanienko J, Servois V, Raizonville L, Coffin F, Romejon J, Hupé P, Chanas L, Dureau S, Frouin E, Mariani O, Antonio S, Callens C, Melaabi S, Masliah-Planchon J, Girard E, Servant N, Kamal M, Bièche I, Paoletti X, Le Tourneau C

Open source

DOI: 10.1158/2767-9764.crc-26-0225
Published: 2026 Sep 1
Container: Cancer research communications
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/2767-9764.crc-26-0225,
  title = {SHIVA02 Trial: Using Patients as Their Own Controls to Assess Efficacy of Therapies Based on Molecular Profiling in Patients with Refractory Cancer.},
  author = {du Rusquec P and Dupain C and Geiss R and Sablin MP and Castel-Ajgal Z and Cassier P and Italiano A and Borcoman E and Klijanienko J and Servois V and Raizonville L and Coffin F and Romejon J and Hupé P and Chanas L and Dureau S and Frouin E and Mariani O and Antonio S and Callens C and Melaabi S and Masliah-Planchon J and Girard E and Servant N and Kamal M and Bièche I and Paoletti X and Le Tourneau C},
  year = {2026},
  journal = {Cancer research communications},
  doi = {10.1158/2767-9764.crc-26-0225},
  url = {https://doi.org/10.1158/2767-9764.crc-26-0225}
}

RIS

TY  - JOUR
TI  - SHIVA02 Trial: Using Patients as Their Own Controls to Assess Efficacy of Therapies Based on Molecular Profiling in Patients with Refractory Cancer.
AU  - du Rusquec P
AU  - Dupain C
AU  - Geiss R
AU  - Sablin MP
AU  - Castel-Ajgal Z
AU  - Cassier P
AU  - Italiano A
AU  - Borcoman E
AU  - Klijanienko J
AU  - Servois V
AU  - Raizonville L
AU  - Coffin F
AU  - Romejon J
AU  - Hupé P
AU  - Chanas L
AU  - Dureau S
AU  - Frouin E
AU  - Mariani O
AU  - Antonio S
AU  - Callens C
AU  - Melaabi S
AU  - Masliah-Planchon J
AU  - Girard E
AU  - Servant N
AU  - Kamal M
AU  - Bièche I
AU  - Paoletti X
AU  - Le Tourneau C
PY  - 2026
JO  - Cancer research communications
DO  - 10.1158/2767-9764.crc-26-0225
UR  - https://doi.org/10.1158/2767-9764.crc-26-0225
ER  -

APA

P, D. R., C, D., R, G., MP, S., Z, C., P, C., A, I., E, B., J, K., V, S., L, R., F, C., J, R., P, H., L, C., S, D., E, F., O, M., S, A., C, C., S, M., J, M., E, G., N, S., M, K., I, B., X, P., & C, L. T. (2026). SHIVA02 Trial: Using Patients as Their Own Controls to Assess Efficacy of Therapies Based on Molecular Profiling in Patients with Refractory Cancer.. Cancer research communications. https://doi.org/10.1158/2767-9764.crc-26-0225

Source records

pubmed · retrieved 2026-09-26T02:33:49.556Z